Follow us

  • X
  • Youtube

News Release

Release
GNI Group Ltd. Announces a Licensing Agreement for its IPF therapy drug Etuary with AFT Pharmaceuticals for the ASEAN, Australasian and CIS Markets
Release
Notice for Exercise of the 37th Round of Stock Options in November, 2013
Release
Notice for Large Volume Exercise of the 37th Round of Stock Options
Release
Patent Allowance for F200 in China
Release
Notice of Development of Topical Medication Product
Release
Notice for Large Volume Exercise of the 37th Round of Stock Options
Release
Notice for Exercise of the 36th Round of Stock Options in October, 2013 and its Acquisition and Cancellation
Release
Notice for Exercise of the 37th Round of Stock Options in October, 2013 and its Acquisition and Cancellation
Release
Notice for Large Volume Exercise of the 37th Round of Stock Options
Release
Notice of Payment for the 37th Round of Stock Options and Partial Acquisition and Cancellation of 37th Round of Stock Options
Release
GNI Announces Acquisition and Cancellation of Stock Acquisition Rights (Third Party Allotment)-Thirty-Sixth Series and Issuance of Stock Acquisition Rights (Third Party Allotment)-Thirty-Seventh Series and Execution of the Third Party Allotment Agreement
Release
Notice for Exercise of the 36th Round of Stock Options in September, 2013
Release
Notice for Patent Grant in Canada and India
Release
Notice for Exercise of the 36th Round of Stock Options in August, 2013
Release
Notice of New Executive Officer